This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Intervet Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Erik Cox
Introduction
Erik Cox is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for livestock. His work focuses on protecting pigs from viral infections, which is crucial for the agricultural industry.
Latest Patents
Erik Cox holds a patent for a vaccine comprising a PCV2 ORF2 protein of genotype 2b. This invention pertains to a vaccine that includes an ORF2 encoded protein of porcine circovirus 2 (PCV2) and a pharmaceutically acceptable carrier. The vaccine is designed to protect pigs against infections caused by porcine circovirus type 2. It is noteworthy that the vaccine comprises less than 20 µg per dose of the ORF2 encoded protein, specifically from a porcine circovirus of genotype 2b.
Career Highlights
Throughout his career, Erik has been associated with Intervet Inc., a company known for its commitment to animal health and welfare. His work at Intervet has allowed him to focus on innovative solutions that address critical health issues in livestock.
Collaborations
Erik Cox collaborates with several talented professionals in his field, including Melanie Sno and Ruud Philip Antoon Maria Segers. These collaborations enhance the research and development efforts at Intervet Inc., leading to advancements in veterinary vaccines.
Conclusion
Erik Cox's contributions to veterinary medicine through his innovative vaccine patent demonstrate his commitment to improving animal health. His work is vital for the agricultural sector, ensuring the well-being of livestock and the sustainability of farming practices.